Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lymphoma, Large-Cell, Follicular”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT05660967
What this trial is testing

Subcutaneous Epcoritamab With or Without Lenalidomide as First Line Therapy for Diffuse Large B-Cell Lymphoma

Who this might be right for
Diffuse Large B-Cell Lymphoma
Genmab 111
Early research (Phase 1)Study completedNCT00004075
What this trial is testing

17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Solid Tumors That Cannot Be Removed By Surgery

Who this might be right for
LymphomaUnspecified Adult Solid Tumor, Protocol Specific
Mayo Clinic
Testing effectiveness (Phase 2)Ended earlyNCT04305444
What this trial is testing

Study of a Triple Combination Therapy, DTRM-555, in Patients With R/R CLL or R/R Non-Hodgkin's Lymphomas

Who this might be right for
Relapsed Chronic Lymphocytic LeukemiaRefractory Chronic Lymphocytic LeukemiaDiffuse Large B Cell Lymphoma+2 more
Zhejiang DTRM Biopharma 55
Early research (Phase 1)Study completedNCT00002750
What this trial is testing

Melphalan in Patients With Neoplastic Meningitis

Who this might be right for
Brain and Central Nervous System TumorsExtragonadal Germ Cell TumorLeukemia+2 more
Duke University 6
Testing effectiveness (Phase 2)Looking for participantsNCT06784726
What this trial is testing

Odronextamab for Relapsed and Refractory Large B-cell Lymphomas Before CAR-T

Who this might be right for
Recurrent Diffuse Large B-Cell LymphomaRecurrent Diffuse Large B-Cell Lymphoma, Not Otherwise SpecifiedRecurrent Grade 3b Follicular Lymphoma+9 more
University of Washington 27
Testing effectiveness (Phase 2)UnknownNCT04089215
What this trial is testing

CD19-targeted CAR T Cells for Relapsed and Refractory (R/R) Non-Hodgkins Lymphoma

Who this might be right for
Lymphoma, Non-HodgkinDiffuse Large B Cell LymphomaFollicular Lymphoma
Shanghai Ming Ju Biotechnology Co., Ltd. 82
Large-scale testing (Phase 3)Study completedNCT00860262
What this trial is testing

Telmisartan and Amlodipine Fixed Dose Combination [FDC] Trial for the Treatment of Severe Hypertension

Who this might be right for
Hypertension
Boehringer Ingelheim 858
Testing effectiveness (Phase 2)Temporarily pausedNCT06761677
What this trial is testing

A Phase 1b/2 Study of Intravenous Brincidofovir in Patients With Relapsed or Refractory Lymphoma and Relapsed or Refractory Extranodal Natural Killer/T-cell Lymphoma

Who this might be right for
Relapsed or Refractory Lymphoma Including ENKL
SymBio Pharmaceuticals 43
Large-scale testing (Phase 3)Study completedNCT00227695
What this trial is testing

Rituximab in Treating Patients With Follicular Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Swiss Cancer Institute 270
Testing effectiveness (Phase 2)Study completedNCT00026351
What this trial is testing

Pentostatin and Rituximab in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia

Who this might be right for
LeukemiaLymphoma
Pharmatech Oncology
Testing effectiveness (Phase 2)Ended earlyNCT03135262
What this trial is testing

Obinutuzumab in Combination With Idasanutlin and Venetoclax in Participants With Relapsed or Refractory (R/R) Follicular Lymphoma (FL) or Rituximab in Combination With Idasanutlin and Venetoclax in Participants With R/R Diffuse Large B-Cell Lymphoma (DLBCL)

Who this might be right for
Follicular LymphomaLymphoma, Large B-Cell, Diffuse
Hoffmann-La Roche 29
Testing effectiveness (Phase 2)Looking for participantsNCT05281809
What this trial is testing

Local Manufacture of CAR T-Cell Products for the Treatment of B-Cell Lymphoma and B-Acute Lymphoblastic Leukemia

Who this might be right for
B-Cell LymphomaB Acute Lymphoblastic LeukemiaDiffuse Large B Cell Lymphoma+6 more
John Lister 30
Early research (Phase 1)Active Not RecruitingNCT05688475
What this trial is testing

A Rollover Study of CC-122

Who this might be right for
Non-Hodgkin Lymphoma
Bristol-Myers Squibb 12
Not applicableEnded earlyNCT03436771
What this trial is testing

Long-term Follow-up Study for Patients Previously Treated With a Juno CAR T-Cell Product

Who this might be right for
Non Hodgkin LymphomaMultiple MyelomaChronic Lymphocytic Leukemia+3 more
Juno Therapeutics, a Subsidiary of Celgene 4
Not applicableStudy completedNCT00005799
What this trial is testing

Fludarabine Phosphate, Low-Dose Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+42 more
Fred Hutchinson Cancer Center 55
Large-scale testing (Phase 3)Study completedNCT00003204
What this trial is testing

Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With Stage III or Stage IV Low-Grade Non-Hodgkin's Lymphoma

Who this might be right for
Stage III Grade 1 Follicular LymphomaStage III Grade 2 Follicular LymphomaStage III Grade 3 Follicular Lymphoma+5 more
National Cancer Institute (NCI) 515
Large-scale testing (Phase 3)Study completedNCT00003414
What this trial is testing

Graft-Versus-Host Disease in Treating Patients With Recurrent or Refractory Lymphoma or Hodgkin's Disease

Who this might be right for
Graft Versus Host DiseaseLymphoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 50
Large-scale testing (Phase 3)UnknownNCT00003337
What this trial is testing

Radiolabeled Monoclonal Antibody in the Detection and Staging of Patients With Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Gilead Sciences 100
Testing effectiveness (Phase 2)WithdrawnNCT00621036
What this trial is testing

Vaccine Therapy and GM-CSF in Treating Patients With CNS Lymphoma

Who this might be right for
Brain and Central Nervous System TumorsLymphomaLymphoproliferative Disorder+1 more
University of Texas Southwestern Medical Center
Early research (Phase 1)Ended earlyNCT04735471
What this trial is testing

ADI-001 in B Cell Malignancies

Who this might be right for
Lymphoma, FollicularLymphoma, Mantle-CellMarginal Zone Lymphoma+3 more
Adicet Therapeutics 34
Next Page